Growth differentiation factor-15: A new biomarker in cardiovascular disease

Herz

Volumn 34, Issue 8, 2009, Pages 594-599

  Kempf, Tibor ^a   Wollert, Kai C ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Biomarker; Coronary artery disease; GDF 15; Heart failure; Prognosis

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CYTOKINE; GROWTH DIFFERENTIATION FACTOR 15; TROPONIN; TROPONIN T;

ACUTE CORONARY SYNDROME; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HIGH RISK PATIENT; HIGH RISK POPULATION; HUMAN; OXIDATIVE STRESS; PATIENT MONITORING; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVIEW; RISK FACTOR; ST SEGMENT ELEVATION; TREATMENT RESPONSE; VASCULAR DISEASE;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CLINICAL TRIALS AS TOPIC; GROWTH DIFFERENTIATION FACTOR 15; HUMANS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 73649110256     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-009-3317-3     Document Type: Review

References (31)

1. A.R. Bauskin D.A. Brown T. Kuffner, et al. 2006 Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer Cancer Res 66 4983 4986 10.1158/0008-5472.CAN-05-4067 1:CAS:528:DC%2BD28XksF2jurg%3D 16707416 (Pubitemid 43852864)
2. B. Bermudez S. Lopez Y.M. Pacheco, et al. 2008 Influence of postprandial triglyceride-rich lipoproteins on lipid-mediated gene expression in smooth muscle cells of the human coronary artery Cardiovasc Res 79 294 303 10.1093/cvr/cvn082 1:CAS:528:DC%2BD1cXot1WisLw%3D 18359786 (Pubitemid 351951608)
3. M.R. Bootcov A.R. Bauskin S.M. Valenzuela, et al. 1997 MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily Proc Natl Acad Sci U S A 94 11514 11519 10.1073/pnas.94.21.11514 1:CAS:528:DyaK2sXmslaqsr0%3D 9326641 (Pubitemid 27451030)
4. E. Braunwald 2008 Biomarkers in heart failure N Engl J Med 358 2148 2159 10.1056/NEJMra0800239 1:CAS:528:DC%2BD1cXlvFCrsL8%3D 18480207 (Pubitemid 351679601)
5. D.A. Brown J. Moore H. Johnen, et al. 2007 Serum macrophage inhibitory cytokine 1 in rheumatoid arthritis: a potential marker of erosive joint destruction Arthritis Rheum 56 753 764 10.1002/art.22410 1:CAS:528: DC%2BD2sXjs1ylu7w%3D 17328047 (Pubitemid 46399422)
6. Q. Ding T. Mracek P. Gonzalez-Muniesa, et al. 2009 Identification of macrophage inhibitory cytokine-1 (MIC-1) in adipose tissue and its secretion as an adipokine by human adipocytes Endocrinology 150 1688 1696 10.1210/en.2008-0952 1:CAS:528:DC%2BD1MXktVWlsr8%3D 19074584
7. K.M. Eggers T. Kempf T. Allhoff, et al. 2008 Growth-differentiation factor-15 for early risk stratification in patients with acute chest pain Eur Heart J 29 2327 2335 10.1093/eurheartj/ehn339 1:CAS:528:DC%2BD1cXhtlGisbvN 18664460
8. N. Ferrari U. Pfeffer R. Dell'Eva, et al. 2005 The transforming growth factor-beta family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydroxyphenyl)-retinamide Clin Cancer Res 11 4610 4619 10.1158/1078-0432. CCR-04-2210 1:CAS:528:DC%2BD2MXltFeksLg%3D 15958647 (Pubitemid 40825652)
9. Foley PW, Stegemann B, Ng K, et al. Growth differentiation factor-15 predicts mortality and morbidity after cardiac resynchronization therapy. Eur Heart J 2009:in press (Epub 8/7/2009).
10. D. Frank C. Kuhn B. Brors, et al. 2008 Gene expression pattern in biomechanically stretched cardiomyocytes: evidence for a stretch-specific gene program Hypertension 51 309 318 10.1161/HYPERTENSIONAHA.107.098046 1:CAS:528:DC%2BD1cXmt1Oitg%3D%3D 18158353 (Pubitemid 351159944)
11. J.S. Hochman J.E. Tamis T.D. Thompson, et al. 1999 Sex, clinical presentation, and outcomes in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes IIb Investigators N Engl J Med 341 226 232 10.1056/NEJM199907223410402 1:STN:280:DyaK1MzivVCqsQ%3D%3D 10413734 (Pubitemid 29334520)
12. M. Jessup S. Brozena 2003 Heart failure N Engl J Med 348 2007 2018 10.1056/NEJMra021498 12748317 (Pubitemid 36569990)
13. T. Kempf E. Bjorklund S. Olofsson, et al. 2007 Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction Eur Heart J 28 2858 2865 10.1093/eurheartj/ehm465 1:CAS:528:DC%2BD1cXhtlaqtL8%3D 17977844 (Pubitemid 350233034)
14. T. Kempf M. Eden J. Strelau, et al. 2006 The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury Circ Res 98 351 360 10.1161/01.RES. 0000202805.73038.48 1:CAS:528:DC%2BD28Xht1Cmurk%3D 16397141 (Pubitemid 43755331)
15. T. Kempf S. von Haehling T. Peter, et al. 2007 Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure J Am Coll Cardiol 50 1054 1060 10.1016/j.jacc.2007.04.091 1:CAS:528: DC%2BD2sXhtVWhtrnE 17825714 (Pubitemid 47348231)
16. T. Kempf R. Horn-Wichmann G. Brabant, et al. 2007 Circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay Clin Chem 53 284 291 10.1373/clinchem.2006. 076828 1:CAS:528:DC%2BD2sXhs1Wrtbg%3D 17185363 (Pubitemid 46338273)
17. T. Kempf J. Sinning A. Quint, et al. 2009 Growth-differentiation factor-15 for risk stratification in patients with stable and unstable coronary heart disease Circ Cardiovasc Genet 2 286 292 10.1161/CIRCGENETICS.108.824870 1:CAS:528:DC%2BD1MXosVOqs7k%3D
18. J.H. Kim K.Y. Kim J.H. Jeon, et al. 2008 Adipocyte culture medium stimulates production of macrophage inhibitory cytokine 1 in MDA-MB-231 cells Cancer Lett 261 253 262 10.1016/j.canlet.2007.11.020 1:CAS:528: DC%2BD1cXitlemtb4%3D 18164124
19. M. Lainscak S.D. Anker 2009 Prognostic factors in chronic heart failure. A review of serum biomarkers, metabolic changes, symptoms, and scoring systems Herz 34 141 147 10.1007/s00059-009-3211-z 19370331
20. M. Lankeit T. Kempf C. Dellas, et al. 2008 Growth differentiation factor-15 for prognostic assessment of patients with acute pulmonary embolism Am J Respir Crit Care Med 177 1018 1025 10.1164/rccm.200712-1786OC 1:CAS:528:DC%2BD1cXms1OhsL0%3D 18263797 (Pubitemid 351717597)
21. L. Lind L. Wallentin T. Kempf, et al. 2009 Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study Eur Heart J 30 2346 2353 10.1093/eurheartj/ehp261 1:CAS:528:DC%2BD1MXht1WrtLfF 19561023
22. A. Maisel C. Mueller K. Adams Jr, et al. 2008 State of the art: using natriuretic peptide levels in clinical practice Eur J Heart Fail 10 824 839 10.1016/j.ejheart.2008.07.014 1:CAS:528:DC%2BD1cXhtFaju7jO 18760965
23. D.A. Morrow J.A. Lemos 2007 Benchmarks for the assessment of novel cardiovascular biomarkers Circulation 115 949 952 10.1161/CIRCULATIONAHA.106. 683110 17325253 (Pubitemid 46328287)
24. N. Nickel T. Kempf H. Tapken, et al. 2008 Growth differentiation factor-15 in idiopathic pulmonary arterial hypertension Am J Respir Crit Care Med 178 534 541 10.1164/rccm.200802-235OC 1:CAS:528:DC%2BD1cXhtFKisLnK 18565955
25. D. Schlittenhardt A. Schober J. Strelau, et al. 2004 Involvement of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions Cell Tissue Res 318 325 333 10.1007/s00441-004-0986-3 1:CAS:528:DC%2BD2cXoslSmtbg%3D 15459768 (Pubitemid 39506502)
26. P. Secchiero F. Corallini A. Gonelli, et al. 2007 Antiangiogenic activity of the MDM2 antagonist nutlin-3 Circ Res 100 61 69 10.1161/01.RES.0000253975. 76198.ff 1:CAS:528:DC%2BD28XhtlGiurjN 17138942 (Pubitemid 46066774)
27. K. Thygesen J.S. Alpert H.D. White, et al. 2007 Universal definition of myocardial infarction Circulation 116 2634 2653 10.1161/CIRCULATIONAHA.107. 187397 17951284 (Pubitemid 350182388)
28. M. Weber C. Hamm 2008 Redefinition of myocardial infarction - relevance of biomarkers Herz 33 115 121 10.1007/s00059-008-3103-7 18344030
29. K.C. Wollert T. Kempf B. Lagerqvist, et al. 2007 Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non ST-elevation acute coronary syndrome Circulation 116 1540 1548 10.1161/CIRCULATIONAHA.107.697714 17848615 (Pubitemid 47511417)
30. K.C. Wollert T. Kempf T. Peter, et al. 2007 Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome Circulation 115 962 971 10.1161/CIRCULATIONAHA.106.650846 1:CAS:528:DC%2BD2sXhvVyqurc%3D 17283261 (Pubitemid 46328289)
31. J. Xu T.R. Kimball J.N. Lorenz, et al. 2006 GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation Circ Res 98 342 350 10.1161/01.RES.0000202804.84885.d0 1:CAS:528:DC%2BD28Xht1Cmurs%3D 16397142 (Pubitemid 43755330)